ストックスクリーナーアプリを入手
31.12
3.11%
-1.00
アフターアワーズ：
31.20
0.08
+0.26%
Moderna Inc (MRNA) 最新ニュース
Rep. Robert Bresnahan, Jr. Buys Moderna, Inc. (NASDAQ:MRNA) Shares - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Vanguard Group Inc. - MarketBeat
KLP Kapitalforvaltning AS Takes $4.44 Million Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Motley Fool Wealth Management LLC Cuts Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Jim Cramer Slams Moderna, Inc. (MRNA) as One of the Year’s Biggest Disappointments - Insider Monkey
Teacher Retirement System of Texas Purchases 12,651 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Sells 26,060 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Stake Lowered by Corient Private Wealth LLC - MarketBeat
Royal London Asset Management Ltd. Sells 178,991 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Is Moderna Stock A Sell With RFK Jr. Reportedly Eyeing Funds? - Investor's Business Daily
Jim Cramer: Moderna (MRNA) Blew It – But Their Cash Pile Could Save Them! - Insider Monkey
Moderna's Options Frenzy: What You Need to Know - Benzinga
Moderna, Inc. (MRNA): Among Stocks To Trade Without Tariffs And Interest Rate Fears - Insider Monkey
Trump administration at ‘war’ with mRNA technology: scientists alarmed vaccine skeptics could kill research - Inkl
As Vaccine Skepticism Mounts, Moderna’s Business Grows More Precarious - Barron's
Moderna chief brand officer Kate Cronin exits pharma giant - MM+M Online
Moderna, Novavax Shares Are Sliding Wednesday: What's Going On?Moderna (NASDAQ:MRNA) - Benzinga
Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts - Investing.com
Raymond James Financial Inc. Takes $8.49 Million Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
JPMorgan Chase & Co. Lowers Moderna (NASDAQ:MRNA) Price Target to $33.00 - MarketBeat
Northwest & Ethical Investments L.P. Grows Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Given Average Rating of "Hold" by Analysts - MarketBeat
Is Moderna, Inc. (MRNA) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey
Moderna, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your RightsMRNA - ACCESS Newswire
USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars? - Crowell & Moring LLP
Moderna, Inc. (MRNA): Among Stocks with Potential to Explode in 2025 - Insider Monkey
Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks - Yahoo Finance
Avantax Advisory Services Inc. Invests $483,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Privium Fund Management B.V. Increases Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
mRNA Patent Wars Update: The Plot Thickens with Key Rulings Expected in 2025 - IPWatchdog.com
Moderna price target lowered to $33 from $40 at JPMorgan - Yahoo Finance
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move - The Motley Fool
Wealthfront Advisers LLC Lowers Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
JPMorgan Cuts Price Target on Moderna to $33 From $40, Maintains Underweight Rating - Marketscreener.com
Proficio Capital Partners LLC Raises Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Swiss National Bank - MarketBeat
Skandinaviska Enskilda Banken AB publ Decreases Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
U.S. to spend $100M to develop bird flu vaccines, drugs (MRNA) (MRNA:NASDAQ) - Seeking Alpha
Moderna's Options: A Look at What the Big Money is Thinking - Benzinga
4 Things You Need to Know if You Buy Moderna Stock Today - Nasdaq
Intact Investment Management Inc. Invests $420,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):